Clinical Trial: RBD5044 in Chinese Participants With Hypertriglyceridemia

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587788) titled 'RBD5044 in Chinese Participants With Hypertriglyceridemia' on May 04.

Brief Summary: The goal of this clinical trial is to learn if drug RBD5044 works to treat hypertriglyceridemia in adults. It will also learn about the safety of drug RBD5044. The main questions it aims to answer are:

Does drug RBD5044 reduce the triglyceride levels? What medical problems may participants experience when taking drug RBD5044? Researchers will compare drug RBD5044 to a placebo to see if drug RBD5044 works to treat hypertriglyceridemia.

Participants will:

Receive RBD5044 or placebo twice during the trial (Day 1 and Day 84).

Study Start Date: Feb. 2...